Advertisement
Screener

Synergy CHC Corp. (SNYR) Overview

Synergy CHC Corp. (SNYR) Overview

  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual -0.23; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual 0.01; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual 0.17; Beat / miss (m).
  • 1 Jan 2025: Period ending 31 Mar 2025; Estimate (m); Actual 0.10; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$0.10$0.19$0.37$0.73$1.44$2.832025-08-272026-08-27$0.10$0.24$0.60$1.50$3.77$9.462024-10-232026-08-27$0.10$0.24$0.60$1.50$3.77$9.462024-10-232026-08-27$0.10$0.24$0.60$1.50$3.77$9.462024-10-232026-08-27$0.10$0.24$0.60$1.50$3.77$9.462024-10-232026-08-27

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$0.11
Previous close
$0.10
Change
$0.01
Change (%)
10.00%
Close date
2026-08-27
Previous close date
2026-08-26
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-08-27

YTD

SNYR
-94.09%
S&P 500
(m)

1 year

SNYR
-94.74%
S&P 500
(m)

3 years

SNYR
(m)
S&P 500
(m)

5 years

SNYR
(m)
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

31 Mar 2026 ○ Estimate (m) ● Actual -0.23

-0.31-0.150.020.180.3530 Sept 2024: estimate (m); actual 0.1130 Sept 2024(m)31 Mar 2025: estimate (m); actual 0.1031 Mar 2025(m)30 Jun 2025: estimate (m); actual 0.1730 Jun 2025(m)30 Sept 2025: estimate (m); actual 0.0130 Sept 2025(m)31 Mar 2026: estimate (m); actual -0.2331 Mar 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202631 Mar 2026(m)-0.23(m)(m)
1 Jul 202530 Sept 2025(m)0.01(m)(m)
1 Apr 202530 Jun 2025(m)0.17(m)(m)
1 Jan 202531 Mar 2025(m)0.10(m)(m)
1 Jul 202430 Sept 2024(m)0.11(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual -1.27

-1.35-0.75-0.160.441.0431 Dec 2018: estimate (m); actual -0.0731 Dec 2018(m)31 Dec 2019: estimate (m); actual -0.1031 Dec 2019(m)31 Dec 2023: estimate (m); actual 0.8631 Dec 2023(m)31 Dec 2024: estimate (m); actual 0.2831 Dec 2024(m)31 Dec 2025: estimate (m); actual -1.2731 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)-1.27(m)(m)
1 Jan 202431 Dec 2024(m)0.28(m)(m)
1 Jan 202331 Dec 2023(m)0.86(m)(m)
1 Jan 201931 Dec 2019(m)-0.10(m)(m)
1 Jan 201831 Dec 2018(m)-0.07(m)(m)

Revenue vs. Earnings

USD

31 Mar 2026 ■ Revenue 5.49M ■ Earnings -2.57M — Profit margin -46.77%

-17.57M-245.3%-8.08M-157.2%1.40M-69.0%10.89M19.1%30 Jun 2025: revenue 8.13M; earnings 1.47M; profit margin 18.11%30 Jun 202530 Sept 2025: revenue 8.01M; earnings 0.13M; profit margin 1.56%30 Sept 202531 Dec 2025: revenue 6.07M*; earnings -14.82M*; profit margin -244.28%*; Revenue: Annual amount − nine-month amount; Earnings: Annual amount − nine-month amount; period 2025-10-01 to 2025-12-31; USD.31 Dec 202531 Mar 2026: revenue 5.49M; earnings -2.57M; profit margin -46.77%31 Mar 2026

31 Dec 2025 ■ Revenue 30.38M ■ Earnings -12.34M — Profit margin -40.62%

-18.96M-41.6%3.83M-22.5%26.61M-3.3%49.39M15.8%31 Dec 2019: revenue 29.36M; earnings -9.21M; profit margin -31.36%31 Dec 201931 Dec 2023: revenue 42.78M; earnings 6.34M; profit margin 14.82%31 Dec 202331 Dec 2024: revenue 34.83M; earnings 2.12M; profit margin 6.10%31 Dec 202431 Dec 2025: revenue 30.38M; earnings -12.34M; profit margin -40.62%31 Dec 2025

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$0.11(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$0.11High(m)Average(m)Low(m)2025-08-272026-08-27

Recent news

View more →

(m)

YouTube videos mentioning SNYR

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending (m).

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
(m)
Profit margin
(m)
Return on assets · 12 month
(m)
Stock compensation expense · all employees · 12 months
(m)
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
Employees
(m)
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
(m)
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
-8.33%*
Total return · month
-35.29%*
Total return · quarter
-56.00%*
Total return · half year
-92.14%*
Total return · year to date
-94.09%*
Total return · 1 year
-94.74%*
Total return · 3 years
(m)
Total return · 5 years
(m)
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
(m)
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

Synergy CHC Corp. Overview

View more →

(m)

(m)

SEC CIK
1562733
Industry (SIC)
2833 Medicinal Chemicals & Botanical Products
Country of operation
United States
Business address
865 SPRING STREET, WESTBROOK, Maine, 04092, United States
Fiscal year end
1231
Phone
615-939-9004

Similar stocks

Stock NameCountryMarket CapPE Ratio
Functional Brands Inc. (MEHA)United States$0.001B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
MANNATECH INC (MTEX)United States$0.014B
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Canopy Growth Corp (CGC)$0.395B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87